The Claim
Surface-displayed ClbS on engineered Escherichia coli prevents colibactin-induced DNA damage in human colon organoids and multiple colorectal cancer cell lines.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Engineered bacteria with ClbS protein on their surface reduce DNA damage caused by a bacterial toxin in human colon tissue models and colorectal cancer cells.
See the scientific wording
Surface-displayed ClbS on engineered Escherichia coli prevents colibactin-induced DNA damage in human colon organoids and multiple colorectal cancer cell lines, demonstrating broad efficacy across physiologically relevant human tissue models.
What the research says
1 studyStudy: Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
Scientists modified harmless E. coli bacteria to wear a special shield (ClbS) on their surface that catches and neutralizes a cancer-causing poison made by other gut bacteria. This shield worked in human gut tissue and cancer cells, proving it can stop the poison from damaging DNA.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.